KRT14 and dysplasia: Transgenic hemizygous mice expressing the complete early genome region (CER) of the betaHPV type 8 (HPV8) under the control of the human keratin-14 (K14)-promoter (referred to as K14-HPV8-CER) develop skin tumours, partially with moderate to severe dysplasia.